|
||||||||||||||||
| HUM-MOLGEN -> Events -> Courses and Workshops | ||||||||||||||||
| From Transgenic Models of Alzheimer’s Disease Inflammation to Clinical Trials with Anti-Inflammatory Drugs - New Evidence for the “Better Aspirin” in Alzheimer’s Disease | ||||||||||||||||
| April 24, 2001 | ||||||||||||||||
|
Mount Sinai School of Medicine in conjunction with Society of Biological Psychiatry, Sheraton New Orleans May 3, 2001 2:30 - 3:05 John C. S. Breitner, MD, MPH The Johns Hopkins University School of Hygiene and Public Health Department of Mental Hygiene EPIDEMIOLOGICAL EVIDENCE FOR A BENEFICIAL ROLE OF NSAIDs IN ALZHEIMER’S DISEASE 3:05 – 3:40 Giulio Maria Pasinetti, MD, PhD Mount Sinai School of Medicine Department of Psychiatry Neuroinflammation Research Center THE ROLE OF NEURONAL CYCLOOXYGENASE (COX-2) IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER’S DISEASE 3:40 – 4:15 Gregory Cole, PhD University of California, Los Angeles Departments of Medicine & Neurology NSAID EFFECTS ON AMYLOID BURDEN 4:15 – 4:50 Paul Aisen, MD Georgetown University Medical Center Department of Neurology ANTI-INFLAMMATORY TREATMENT OF ALZHEIMER’S DISEASE |
||||||||||||||||
| Organized by: | Giulio Maria Pasinetti, MD, PhD | |||||||||||||||
| Invited Speakers: | John C. S. Breitner, MD, MPH Giulio Maria Pasinetti, MD, PhD Gregory Cole, PhD Paul Aisen, MD |
|||||||||||||||
| Deadline for Abstracts: | N/A | |||||||||||||||
| Registration: | see Society of Biological Psychiatry's 56TH ANNUAL SCIENTIFIC CONVENTION AND PROGRAM | |||||||||||||||
| E-mail: | meetings@worldeventsforum.com | |||||||||||||||
| Posted by: | Nico Stanculescu | |||||||||||||||
| Host: | dyn-66-72-127-191.chicago.il.ameritech.net | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||